10/21/24 15:49 | 10/19/24 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Collard Craig A | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 14 | 5 | 290 | D | | | | | | | | | | | | | | |
7/22/24 09:54 | 7/19/24 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Collard Craig A | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 14 | 5 | 277 | D | | | | | | | | | | | | | | |
4/19/24 16:34 | 4/19/24 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Collard Craig A | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 14 | 6 | 263 | D | | | | | | | | | | | | | | |
4/5/24 15:57 | 4/3/24 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Collard Craig A | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 63 | 34 | 249 | D | | | | | | | | | | | | | | |
11/17/23 12:37 | 11/16/23 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Collard Craig A | CA | DO | CEO | P | 138 | 0.9198 | 0 | 150 | 411 | 186 | D | | | | | | | | | | | | | | |
9/27/22 12:00 | 9/23/22 | TRSSF | Terrascend Corp. | A6 | Ag | Ag | Crops | Collard Craig A | A6 | D | | P | 0 | 0.00 | 0 | 60 | 17 | 421 | D | | | | | | | | | | | | | | |
9/26/22 12:26 | 9/22/22 | TRSSF | Terrascend Corp. | A6 | Ag | Ag | Crops | Collard Craig A | A6 | D | | P | 0 | 0.00 | 0 | 120 | 50 | 361 | D | | | | | | | | | | | | | | |
6/13/22 16:55 | 6/10/22 | OPNT | Opiant Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Collard Craig A | CA | D | | P.m | 63 | 11.10 | 0 | 6 | 12 | 54 | D | | | | | | | | | | | | | | |
5/17/22 16:02 | 5/16/22 | OPNT | Opiant Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Collard Craig A | CA | D | | P | 368 | 13.54 | 0 | 27 | 129 | 48 | D | | | | | | | | | | | | | | |
5/16/22 16:05 | 5/13/22 | OPNT | Opiant Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Collard Craig A | CA | D | | P | 39 | 10.49 | 0 | 4 | 21 | 21 | D | | | | | | | | | | | | | | |